Predictors of severity and in-hospital mortality in patients with influenza

被引:2
作者
Serino, Mariana [1 ]
Melo, Nuno [2 ]
Caldas, Joao Paulo [3 ]
Ferreira, Ana [2 ]
Garcia, David [4 ]
Lourenco, Patricia [2 ]
机构
[1] EPE, Ctr Hosp Univ Sao Joao, Dept Pneumol, Porto, Portugal
[2] EPE, Ctr Hosp Univ Sao Joao, Dept Internal Med, Porto, Portugal
[3] EPE, Ctr Hosp Univ Sao Joao, Dept Infect Dis, Porto, Portugal
[4] EPE, Ctr Hosp Univ Sao Joao, Dept Clin Pathol, Porto, Portugal
关键词
infection; influenza virus; severity predictors; mortality; NEURAMINIDASE INHIBITORS; DISEASE SEVERITY; ADULTS; PREVENTION; OUTCOMES;
D O I
10.4081/monaldi.2021.1876
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Influenza virus is a common agent of acute respiratoty infections during epidemic periods. It is a major cause of morbidity and mortality and represent a significant burden on the healthcare system. We aimed to evaluate predictors of severity and of in-hospital mortality in patients hospitalized with influenza infection. We performed a retrospective cohort study of hospitalized, laboratory confirmed cases of influenza disease in Centro Hospitalar de Sao Joao between October 2016-May 2017 and October 2017-May 2018. The endpoints being analysed were severity and in-hospital mortality. A multivariate logistic regression analysis was used to determine independent predictors of severity and of in-hospital mortality. We studied 221 hospitalized influenza infection cases. Mean age 66 +/- 16 years, 57.9% were male, thirty-seven patients (16.7%) died in-hospital and 101 patients (45.7%) met severity criteria. C-reactive protein (CRP) was the only independent predictor of severity as well as the only independent predictor of higher in-hospital mortality in patients admitted due to influenza infection. Multivariate-adjusted CRP OR for severity was 1.10, 95% CI 1.06-1.15 per each 10 mg/L increase in CPR and for in-hospital mortality risk the OR was of 1.05, 95% CI 1.01-1.09, p = 0.01, per each 10 mg/L increase. Concluding, in patients' hospital-admitted due to influenza infection CRP was the only predictor of severity with a 10% increased risk of inotropic support/ventilatory support/prolonged hospitalization needs and a 5% increased risk of in-hospital death per each 10 mg/l increase.
引用
收藏
页数:5
相关论文
共 23 条
  • [1] Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza
    Arriola, Carmen
    Garg, Shikha
    Anderson, Evan J.
    Ryan, Patrician A.
    George, Andrea
    Zansky, Shelley M.
    Bennett, Nancy
    Reingold, Arthur
    Bargsten, Marisa
    Miller, Lisa
    Yousey-Hindes, Kimberly
    Tatham, Lilith
    Bohm, Susan R.
    Lynfield, Ruth
    Thomas, Ann
    Lindegren, Mary Lou
    Schaffner, William
    Fry, Alicia M.
    Chaves, Sandra S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 65 (08) : 1289 - 1297
  • [2] Prevention and Treatment of Cancer-Related Infections, Version 2.2016
    Baden, Lindsey Robert
    Swaminathan, Sankar
    Angarone, Michael
    Blouin, Gayle
    Camins, Bernard C.
    Casper, Corey
    Cooper, Brenda
    Dubberke, Erik R.
    Engemann, Ashley Morris
    Freifeld, Alison G.
    Greene, John N.
    Ito, James I.
    Kaul, Daniel R.
    Lustberg, Mark E.
    Montoya, Jose G.
    Rolston, Ken
    Satyanarayana, Gowri
    Segal, Brahm
    Seo, Susan K.
    Shoham, Shmuel
    Taplitz, Randy
    Topal, Jeffrey
    Wilson, John W.
    Hoffmann, Karin G.
    Smith, Courtney
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07): : 882 - 913
  • [3] Epidemic Influenza - Responding to the Expected but Unpredictable
    Bresee, Joseph
    Hayden, Frederick G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07) : 589 - 592
  • [4] Clinical features, treatments and outcomes of influenza A (H1N1) 2009 among the hospitalized patients in the Clinic for Infectious Diseases in Novi Sad
    Canak, Grozdana
    Kovacevic, Nadica
    Vukadinov, Jovan
    Turkulov, Vesna
    Sevic, Sinisa
    Doder, Radoslava
    Somborac, Stevan
    Potkonjak, Aleksandar
    [J]. VOJNOSANITETSKI PREGLED, 2013, 70 (02) : 155 - 162
  • [5] Center for Disease Control and Prevention, PREV FLU
  • [6] Patients Hospitalized With Laboratory-Confirmed Influenza During the 2010-2011 Influenza Season: Exploring Disease Severity by Virus Type and Subtype
    Chaves, Sandra S.
    Aragon, Deborah
    Bennett, Nancy
    Cooper, Tara
    D'Mello, Tiffany
    Farley, Monica
    Fowler, Brian
    Hancock, Emily
    Kirley, Pam Daily
    Lynfield, Ruth
    Ryan, Patricia
    Schaffner, William
    Sharangpani, Ruta
    Tengelsen, Leslie
    Thomas, Ann
    Thurston, Diana
    Williams, Jean
    Yousey-Hindes, Kimberly
    Zansky, Shelley
    Finelli, Lyn
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (08) : 1305 - 1314
  • [7] Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials
    Cooper, NJ
    Sutton, AJ
    Abrams, KR
    Wailoo, A
    Turner, DA
    Nicholson, KG
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7401): : 1235 - +
  • [8] Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
    Dobson, Joanna
    Whitley, Richard J.
    Pocock, Stuart
    Monto, Arnold S.
    [J]. LANCET, 2015, 385 (9979) : 1729 - 1737
  • [9] European Centre for Disease Prevention and Control, INFL VIR CHAR
  • [10] C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases
    Gao, Rongbao
    Wang, Lijie
    Bai, Tian
    Zhang, Ye
    Bo, Hong
    Shu, Yuelong
    [J]. EBIOMEDICINE, 2017, 22 : 133 - 142